Cannara Biotech Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LOVFF research report →
Companycannara.ca
Cannara Biotech Inc. , together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform.
- CEO
- Zohar Krivorot
- IPO
- 2019
- Employees
- 461
- HQ
- Saint-Laurent, QC, CA
Price Chart
Valuation
- Market Cap
- $124.47M
- P/E
- 13.81
- P/S
- 1.53
- P/B
- 1.47
- EV/EBITDA
- 7.03
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 38.59%
- Op Margin
- 14.08%
- Net Margin
- 10.48%
- ROE
- 11.63%
- ROIC
- 7.23%
Growth & Income
- Revenue
- $107.32M · 31.28%
- Net Income
- $13.08M · 103.09%
- EPS
- $0.14 · 120.13%
- Op Income
- $22.20M
- FCF YoY
- 324.86%
Performance & Tape
- 52W High
- $1.47
- 52W Low
- $0.81
- 50D MA
- $1.31
- 200D MA
- $1.29
- Beta
- 0.38
- Avg Volume
- 8.31K
Get TickerSpark's AI analysis on LOVFF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our LOVFF Coverage
We haven't published any research on LOVFF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LOVFF Report →